159 related articles for article (PubMed ID: 36410226)
1. Interdisciplinary care of children with diffuse midline glioma.
Coleman C; Chen K; Lu A; Seashore E; Stoller S; Davis T; Braunstein S; Gupta N; Mueller S
Neoplasia; 2023 Jan; 35():100851. PubMed ID: 36410226
[TBL] [Abstract][Full Text] [Related]
2. Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma.
Lee JH; Holste KG; Bah MG; Franson AT; Garton HJL; Maher CO; Muraszko KM
J Neurosurg Pediatr; 2024 Jun; 33(6):507-515. PubMed ID: 38489807
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
[TBL] [Abstract][Full Text] [Related]
4. A homogeneous treatment for non-DIPG diffuse midline glioma.
Schiavello E; Biassoni V; Gattuso G; Podda M; Chiaravalli S; Barretta F; Antonelli M; De Cecco L; Pecori E; Gandola L; Massimino M
Tumori; 2023 Jun; 109(3):269-275. PubMed ID: 35708347
[TBL] [Abstract][Full Text] [Related]
5. Measuring the pons: a non-invasive biomarker for pediatric diffuse intrinsic pontine glioma.
Warren KE
CNS Oncol; 2014 May; 3(3):181-3. PubMed ID: 25055124
[No Abstract] [Full Text] [Related]
6. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
Hennika T; Becher OJ
J Child Neurol; 2016 Oct; 31(12):1377-85. PubMed ID: 26374787
[TBL] [Abstract][Full Text] [Related]
7. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
Lobon-Iglesias MJ; Giraud G; Castel D; Philippe C; Debily MA; Briandet C; Fouyssac F; de Carli E; Dufour C; Valteau-Couanet D; Sainte-Rose C; Blauwblomme T; Beccaria K; Zerah M; Puget S; Calmon R; Boddaert N; Bolle S; Varlet P; Grill J
J Neurooncol; 2018 Mar; 137(1):111-118. PubMed ID: 29198053
[TBL] [Abstract][Full Text] [Related]
8. Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.
Infinger LK; Stevenson CB
Curr Neuropharmacol; 2017; 15(1):129-133. PubMed ID: 27109746
[TBL] [Abstract][Full Text] [Related]
9. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.
Williams JR; Young CC; Vitanza NA; McGrath M; Feroze AH; Browd SR; Hauptman JS
Neurosurg Focus; 2020 Jan; 48(1):E4. PubMed ID: 31896081
[TBL] [Abstract][Full Text] [Related]
10. Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.
Kaye EC; Baker JN; Broniscer A
CNS Oncol; 2014 Nov; 3(6):421-31. PubMed ID: 25438813
[TBL] [Abstract][Full Text] [Related]
11. Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting.
Parekh K; LeBlang S; Nazarian J; Mueller S; Zacharoulis S; Hynynen K; Powlovich L
Neoplasia; 2023 Mar; 37():100876. PubMed ID: 36709715
[TBL] [Abstract][Full Text] [Related]
12. Diffuse intrinsic pontine gliomas: treatments and controversies.
Bredlau AL; Korones DN
Adv Cancer Res; 2014; 121():235-259. PubMed ID: 24889533
[TBL] [Abstract][Full Text] [Related]
13. Tissue sampling in diffuse intrinsic pontine glioma (DIPG) at progression.
Castañeda Heredia A; Puerta Roldan P; Guillen Quesada A; Sunol Capella M; de Torres Gomez-Pallete C; Muchart J; Cruz Martinez O; Mora J; Morales La Madrid A
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233413
[No Abstract] [Full Text] [Related]
14. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
[TBL] [Abstract][Full Text] [Related]
15. Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.
de Billy E; Pellegrino M; Orlando D; Pericoli G; Ferretti R; Businaro P; Ajmone-Cat MA; Rossi S; Petrilli LL; Maestro N; Diomedi-Camassei F; Pezzullo M; De Stefanis C; Bencivenga P; Palma A; Rota R; Del Bufalo F; Massimi L; Weber G; Jones C; Carai A; Caruso S; De Angelis B; Caruana I; Quintarelli C; Mastronuzzi A; Locatelli F; Vinci M
Neuro Oncol; 2022 Jul; 24(7):1150-1163. PubMed ID: 34964902
[TBL] [Abstract][Full Text] [Related]
16. An atypical presentation of diffuse midline pontine glioma in a middle age patient: Case report.
Floro S; Belvedere D; Rosci C; Secchi M; Casellato C; Oggioni G; Gambini C; Campiglio L; Zardoni M; Altavilla R; Bianchi F; D'Arrigo A; Bartesaghi F; Egidi M; Uggetti C; Giaccone G; Marucci G; Mastronuzzi A; Vinci M; Priori A
J Clin Neurosci; 2020 Jan; 71():293-295. PubMed ID: 31548089
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.
Panditharatna E; Yaeger K; Kilburn LB; Packer RJ; Nazarian J
Cancer Genet; 2015; 208(7-8):367-73. PubMed ID: 26206682
[TBL] [Abstract][Full Text] [Related]
18. Diffuse intrinsic pontine glioma: time for therapeutic optimism.
Khatua S; Zaky W
CNS Oncol; 2014; 3(5):337-48. PubMed ID: 25363006
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.
Hashizume R
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):331-342. PubMed ID: 28592748
[TBL] [Abstract][Full Text] [Related]
20. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
El-Khouly FE; Veldhuijzen van Zanten SEM; Santa-Maria Lopez V; Hendrikse NH; Kaspers GJL; Loizos G; Sumerauer D; Nysom K; Pruunsild K; Pentikainen V; Thorarinsdottir HK; Rutkauskiene G; Calvagna V; Drogosiewicz M; Dragomir M; Deak L; Kitanovski L; von Bueren AO; Kebudi R; Slavc I; Jacobs S; Jadrijevic-Cvrlje F; Entz-Werle N; Grill J; Kattamis A; Hauser P; Pears J; Biassoni V; Massimino M; Lopez Aguilar E; Torsvik IK; Joao Gil-da-Costa M; Kumirova E; Cruz-Martinez O; Holm S; Bailey S; Hayden T; Thomale UW; Janssens GOR; Kramm CM; van Vuurden DG
J Neurooncol; 2019 Oct; 145(1):177-184. PubMed ID: 31522324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
